These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 28446292)
21. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma]. Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002 [TBL] [Abstract][Full Text] [Related]
22. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens]. Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248 [No Abstract] [Full Text] [Related]
23. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma. Ahmadvand M; Eskandari M; Pashaiefar H; Yaghmaie M; Manoochehrabadi S; Khakpour G; Sheikhsaran F; Montazer Zohour M Leuk Res; 2018 Jul; 70():45-48. PubMed ID: 29807272 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma. Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264 [TBL] [Abstract][Full Text] [Related]
25. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting. Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315 [TBL] [Abstract][Full Text] [Related]
26. [The Expression and Correlation of Li Y; Liu XY; Cui GR; Kong XY; Yang L; Luo JM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):120-124. PubMed ID: 36765487 [TBL] [Abstract][Full Text] [Related]
27. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin. Sun N; Wang CY; Sun YQ; Ruan YJ; Huang YY; Su T; Zhou XH; Huang H; Guo WJ; He MQ; Yao RX; Lin XJ Biomed Pharmacother; 2018 Oct; 106():267-274. PubMed ID: 29966970 [TBL] [Abstract][Full Text] [Related]
28. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma]. Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247 [No Abstract] [Full Text] [Related]
29. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma]. Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715 [TBL] [Abstract][Full Text] [Related]
30. [Expression of miR-224 in diffuse large B cell lymphoma and its clinical significance]. Song G; Gu L; He B; Pan Y; Wang S Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):619-22. PubMed ID: 25052605 [TBL] [Abstract][Full Text] [Related]
31. Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma. Ji Q; Jiang T; Su J; Zhang S; Li C; Yang X; Wu X; Yao J; Yuan D; Wang J Acta Biochim Pol; 2022 Jun; 69(2):379-385. PubMed ID: 35691029 [TBL] [Abstract][Full Text] [Related]
32. [Expression and Function of miR-181b in Diffuse Large B Cell Lymphoma]. He B; Zhu DX; Chao HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1111-1115. PubMed ID: 30111416 [TBL] [Abstract][Full Text] [Related]
33. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma. Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between Polymorphism of miR-155 and Its Target Gene MyD88 and Clinicopathological Features of Diffuse Large B-cell Lymphoma]. Li Y; Jia ZW; Kong XY; Cui GR; Liu XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):757-762. PubMed ID: 34105469 [TBL] [Abstract][Full Text] [Related]
35. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma. Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824 [TBL] [Abstract][Full Text] [Related]
36. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152 [TBL] [Abstract][Full Text] [Related]
37. [Expression of Bcl-2 gene and its effect on prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma]. Zhang L; Zhao H; Li X; Xia B; Zheng H; Li H; Sun B; Zhang Y Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):755-60. PubMed ID: 25567306 [TBL] [Abstract][Full Text] [Related]
38. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone. Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464 [TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis. Zheng Z; Li X; Zhu Y; Gu W; Xie X; Jiang J Cell Physiol Biochem; 2016; 39(5):1891-1904. PubMed ID: 27771712 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma]. Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]